Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Organigram Global ( (TSE:OGI) ) just unveiled an announcement.
Organigram Global Inc., a leading licensed producer of cannabis, has mailed and filed its management information circular and related materials for an annual and special shareholder meeting scheduled for March 30, 2026 in Toronto. Shareholders of record as of February 23, 2026 will be able to vote in person on routine annual matters and a key transaction resolution, with proxy voting advised before the March 26, 2026 deadline.
At the March 30, 2026 meeting, Organigram shareholders will vote on approving the previously announced acquisition of all remaining shares of German cannabis company Sanity Group GmbH for an upfront €113.4 million plus up to €113.8 million in earnouts, and on a related private placement with BAT raising C$65.2 million. The board, backed by an independent fairness opinion, unanimously recommends supporting the deal, which is expected to be financially accretive, create a vertically integrated European hub centered on Germany’s fast-growing cannabis market, expand Organigram’s retail footprint in Europe, and strengthen its brands and intellectual property, subject to shareholder and regulatory approvals.
The most recent analyst rating on (TSE:OGI) stock is a Buy with a C$3.50 price target. To see the full list of analyst forecasts on Organigram Global stock, see the TSE:OGI Stock Forecast page.
Spark’s Take on TSE:OGI Stock
According to Spark, TipRanks’ AI Analyst, TSE:OGI is a Neutral.
The score is held back primarily by weak operating profitability and negative cash flow despite revenue growth, reinforced by bearish technicals (below key moving averages and negative MACD). A low-leverage balance sheet and a moderate P/E provide partial support but are not enough to offset the core earnings and cash-flow risks.
To see Spark’s full report on TSE:OGI stock, click here.
More about Organigram Global
Organigram Global Inc. is a NASDAQ Global Select Market and TSX-listed Canadian cannabis company whose wholly owned subsidiary, Organigram Inc., is a licensed cultivator of cannabis and manufacturer of cannabis-derived products. Through acquisitions such as Collective Project Limited, Organigram is expanding its participation in branded and value-added cannabis goods, with a growing focus on international markets and higher-margin product formats.
Average Trading Volume: 375,355
Technical Sentiment Signal: Sell
Current Market Cap: C$263.5M
See more data about OGI stock on TipRanks’ Stock Analysis page.